168 related articles for article (PubMed ID: 34380590)
1. The impact of liver disease on mortality in cystic fibrosis-A systematic review.
Sasame A; Stokes D; Bourke B; Connolly L; Fitzpatrick E; Rowland M
J Cyst Fibros; 2022 Mar; 21(2):202-211. PubMed ID: 34380590
[TBL] [Abstract][Full Text] [Related]
2. The impact of liver disease on mortality in cystic fibrosis - a systematic review protocol.
Sasame A; Connolly L; Fitzpatrick E; Stokes D; Bourke B; Rowland M
HRB Open Res; 2020; 3():44. PubMed ID: 33305166
[No Abstract] [Full Text] [Related]
3. The natural history of cystic fibrosis liver disease a prospective cohort study.
Rowland M; Drummond J; Connolly L; Daly E; McCormick PA; Bourke B; ;
J Cyst Fibros; 2023 Nov; 22(6):1054-1061. PubMed ID: 37495468
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and characteristics of cystic fibrosis liver disease: a study highlighting the lack of histological diagnosis.
Issa Z; Gohy S; Zech F; Baldin P; Delire B; Dahlqvist G
Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101977. PubMed ID: 35772685
[TBL] [Abstract][Full Text] [Related]
5. Advanced but not mild liver disease is a predictor of decreased survival in children with cystic fibrosis, with far greater impact in females: A 27-year real-life cohort study.
Baldissera M; Lewindon PJ; Ramm LE; Hartel GF; Mattiello R; Ramm GA
J Cyst Fibros; 2022 Mar; 21(2):230-235. PubMed ID: 34949555
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis-associated liver disease in children.
Wasuwanich P; Karnsakul W
Minerva Pediatr; 2020 Oct; 72(5):440-447. PubMed ID: 32418413
[TBL] [Abstract][Full Text] [Related]
7. Hepatic Manifestations of Cystic Fibrosis.
Sakiani S; Kleiner DE; Heller T; Koh C
Clin Liver Dis; 2019 May; 23(2):263-277. PubMed ID: 30947876
[TBL] [Abstract][Full Text] [Related]
8. The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study.
Dajti E; Ravaioli F; Paiola G; Volpi S; Colecchia L; Ferrarese A; Alemanni LV; Cusumano C; Di Biase AR; Marasco G; Vestito A; Festi D; Rautou PE; Cipolli M; Colecchia A
Liver Int; 2023 Nov; 43(11):2492-2502. PubMed ID: 37724776
[TBL] [Abstract][Full Text] [Related]
9. Genetic modifiers of liver disease in cystic fibrosis.
Bartlett JR; Friedman KJ; Ling SC; Pace RG; Bell SC; Bourke B; Castaldo G; Castellani C; Cipolli M; Colombo C; Colombo JL; Debray D; Fernandez A; Lacaille F; Macek M; Rowland M; Salvatore F; Taylor CJ; Wainwright C; Wilschanski M; Zemková D; Hannah WB; Phillips MJ; Corey M; Zielenski J; Dorfman R; Wang Y; Zou F; Silverman LM; Drumm ML; Wright FA; Lange EM; Durie PR; Knowles MR;
JAMA; 2009 Sep; 302(10):1076-83. PubMed ID: 19738092
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis-related liver disease is an independent risk factor for mortality and increased health care resource utilization in hospitalized pediatric patients with cystic fibrosis.
Thavamani A; Umapathi KK; Kutney K; Sferra TJ; Sankararaman S
Pediatr Pulmonol; 2022 Jul; 57(7):1717-1725. PubMed ID: 35499220
[TBL] [Abstract][Full Text] [Related]
11. Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation.
Chryssostalis A; Hubert D; Coste J; Kanaan R; Burgel PR; Desmazes-Dufeu N; Soubrane O; Dusser D; Sogni P
J Hepatol; 2011 Dec; 55(6):1377-82. PubMed ID: 21703187
[TBL] [Abstract][Full Text] [Related]
12. Utility of transient elastography in the non-invasive evaluation of cystic fibrosis liver disease.
Kitson MT; Kemp WW; Iser DM; Paul E; Wilson JW; Roberts SK
Liver Int; 2013 May; 33(5):698-705. PubMed ID: 23432782
[TBL] [Abstract][Full Text] [Related]
13. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR
PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979
[TBL] [Abstract][Full Text] [Related]
14. Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity.
Koh C; Sakiani S; Surana P; Zhao X; Eccleston J; Kleiner DE; Herion D; Liang TJ; Hoofnagle JH; Chernick M; Heller T
Hepatology; 2017 Aug; 66(2):591-601. PubMed ID: 28422310
[TBL] [Abstract][Full Text] [Related]
15. The Efficacy of MRI in the diagnostic workup of cystic fibrosis-associated liver disease: A clinical observational cohort study.
Poetter-Lang S; Staufer K; Baltzer P; Tamandl D; Muin D; Bastati N; Halilbasic E; Hodge JC; Trauner M; Kazemi-Shirazi L; Ba-Ssalamah A
Eur Radiol; 2019 Feb; 29(2):1048-1058. PubMed ID: 30054796
[TBL] [Abstract][Full Text] [Related]
16. Clinical and genetic risk factors for cystic fibrosis-related liver disease in Egyptian CF children: A single-center experience.
El-Faramawy A; Nasr SZ; Emam MMSA; Fahmy HMH
Pediatr Pulmonol; 2024 Feb; 59(2):465-471. PubMed ID: 38038166
[TBL] [Abstract][Full Text] [Related]
17. SERPINA1 Z allele is associated with cystic fibrosis liver disease.
Boëlle PY; Debray D; Guillot L; Corvol H;
Genet Med; 2019 Sep; 21(9):2151-2155. PubMed ID: 30739910
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis.
Sadler MD; Crotty P; Fatovich L; Wilson S; Rabin HR; Myers RP
Can J Gastroenterol Hepatol; 2015 Apr; 29(3):139-44. PubMed ID: 25855877
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease.
van de Peppel IP; Bertolini A; Jonker JW; Bodewes FAJA; Verkade HJ
Curr Opin Pulm Med; 2017 Nov; 23(6):562-569. PubMed ID: 28837442
[TBL] [Abstract][Full Text] [Related]
20. A Multidisciplinary Approach to Pretransplant and Posttransplant Management of Cystic Fibrosis-Associated Liver Disease.
Freeman AJ; Sellers ZM; Mazariegos G; Kelly A; Saiman L; Mallory G; Ling SC; Narkewicz MR; Leung DH
Liver Transpl; 2019 Apr; 25(4):640-657. PubMed ID: 30697907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
